Granules today said all annual facility fees as required under GDUFA, was paid before due date. Money Control, 1 month ago
The Bulk Pharmaceuticals Task Force (BPTF), an affiliate of the Society of Chemical Manufacturers and Affiliates, asked FDA at a June 15 public meeting to consider several changes to performance goals and the fee payment schedule prior to ...PharmTech.com, 2 months ago BPTF Seeks Changes in Performance Goals, Fee Payment Schedule in GDUFA Renegotiations Biotechgate, 2 months ago
Indian pharma companies may finally be looking at a better rate of clearances from the US Food and Drug… In order to access this content you need to be logged into the site and have an active subscription or trial subscription. Please login , ...Pharma Letter, 1 month ago Drug firms bank on faster US approvals Calcutta Telegraph, 2 months ago
The FDA has warned three generics makers for failing to pay GDUFA fees during the last three fiscal years. The companies —Syntho Pharmaceuticals of Farmingdale, N.Y., Sharon Bio-Medicine of Dehradun, Uttarakhand in India, and Wuxi Kaili ...FDA News, 1 month ago FDA, Generic Manufacturers Want Faster GDUFA Approvals FDA News, 2 months ago Generics Industry Calls for Changes to GDUFA PharmExec.com, 2 months ago
In a statement by Ralph Neas, president and chief executive of the US trade group the Generic Pharmaceutical… In order to access this content you need to be logged into the site and have an active subscription or trial subscription. Please login ...Pharma Letter, 2 months ago Statement by Ralph G. Neas, President and CEO, GPhA, on the June 15th FDA Public Meeting on GDUFA Pharmacy Times, 2 months ago
The U.S. FDA published medical device and generic drug user fee rates for FY 2016. Registrar Corp reports on the fees. Hampton, VA (PRWEB) August 05, 2015 In early August each year, the U.S. Food and Drug Administration (FDA) publishes various ...Virtual Strategy Magazine, 3 weeks ago
Generic Drug User FeeAbbreviated New Drug Application, Prior Approval Supplement, Drug Master File, Final Dosage Form Facility, and Active...
Generic Drug User FeeAbbreviated New Drug Application, Prior Approval Supplement, Drug Master File, Final Dosage Form Facility, and Active Pharmaceutical Ingredient Facility Fee Rates for Fiscal Year 2016 Notice. Citation: "80 FR 46015" ...Pharmacy Choice, 3 weeks ago Food and Drug Administration Warns Sharon Bio Medicine on Generic Drug-User Fee Med India, 1 month ago
Targeted News Service WASHINGTON, Aug. 2 The Department of Health & Human Services published the following notice in the Federal Register from the Food & Drug Administration: Generic Drug User Fee-Abbreviated New Drug Application, Prior ...Pharmacy Choice, 3 weeks ago USFDA issues warning letter to Sharon Bio-medicine Money Control, 1 month ago US FDA asks Sharon Bio to pay user fee dues Hindu Business Line, 1 month ago US Drug Regulator Issues Warning Letter to Sharon Bio-Medicine NDTV Profit, 1 month ago
The benchmark BSE Sensex , NSE Nifty opened in green on Friday, thereby continuing Thursday's winning streak despite mixed global trends today. (Express Photo) The benchmark BSE Sensex rocketed 409 points at 28,114.56 on Friday on continued ...Financial Express, 3 weeks ago BSE Sensex ends 142 points up, Dr Reddy's stocks surge nearly 6%; NSE Nifty below 8,450 Financial Express, 4 weeks ago BSE Sensex ends 43.19 points down at 28,420.12; NSE Nifty reclaims 8,600 Financial Express, 1 month ago Live: Sensex recovers 87.74 points to end at 27,661.40 Livemint.com, 1 month ago
In a report published Friday, Roth Capital Partners analyst Scott R. Henry upgraded the rating on IGI Laboratories, Inc. (NYSE: IG) from Neutral to Buy, while raising the price target from $7 to $11. Analyst Scott R Henry cited "stabilization of ...Benzinga.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!